ART duration and immunometabolic state determine efficacy of DC-based treatment restoring functional HIV- specific CD8+ T cells in PLWH.
M. Calvet-Mirabent, I. Sanchez-Cerrillo, N. Martin-Cofreces, H. De La Fuente, I. Tsukalov, C. Delgado-Arevalo, M. J. Calzada, I. Santos, J. Sanz, L. Garcia-Fraile, F. Sanchez-Madrid, A. Alfranca, M. A. Munoz-Fernandez, M. J. Buzon, E. M.-G. Martin-Gayo
This study shows that ART duration affects CD8+ T cell function in HIV-1 patients, with longer ART improving DC-based immunotherapy outcomes through specific immunometabolic changes.
bioRxiv · Jan 14, 2022 · PreprintImmunology